LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Intravenous Fosfomycin (ZTI-01) for the Treatment of Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP): Results from a Multi-center, Randomized, Double-Blind Phase 2/3 Study in Hospitalized Adults (ZEUS)

Photo by satheeshsankaran from unsplash

Keith S. Kaye, MD, MPH1, Louis B. Rice, MD, FIDSA2, Aaron Dane, PhD3, Viktor Stus, MD, PhD4, Olexsiy Sagan, MD5, Elena Fedosiuk, MD6, Anita Das, PhD7, David Skarinsky, BS8, Paul… Click to show full abstract

Keith S. Kaye, MD, MPH1, Louis B. Rice, MD, FIDSA2, Aaron Dane, PhD3, Viktor Stus, MD, PhD4, Olexsiy Sagan, MD5, Elena Fedosiuk, MD6, Anita Das, PhD7, David Skarinsky, BS8, Paul B Eckburg, MD8 and Evelyn J Ellis-Grosse, PhD9, (1)University of Michigan Medical School, Ann Arbor, MI, (2)Brown University, Providence, RI, (3)DaneStat Consulting, Alderley Edge, United Kingdom, (4)Municipal Institution Dnipropetrovsk Medical Academy of MOH of Ukraine, Dnipropetrovsk, Ukraine, (5)Department of Urology, Communal Institution Zaporizhzhia Regional Clinical Hospital, Zaporizhzhia, Ukraine, (6)Brest Regional Hospital, Brest, Belarus, (7)Das Statistical Consulting, Guerneville, CA, (8)Zavante Therapeutics, Inc., San Diego, CA, (9)Zavante Therapeutics, Inc, San Diego, CA

Keywords: urinary tract; intravenous fosfomycin; complicated urinary; fosfomycin zti; zti treatment; treatment complicated

Journal Title: Open Forum Infectious Diseases
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.